Dow Down 0.92% Nasdaq Down 0.83%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
27.66 Down 1.03(3.59%) 4:00PM EDT
|After Hours : 27.65 Down 0.01 (0.04%) 7:50PM EDT
Prev Close:28.69
Open:28.61
Bid:27.65 x 300
Ask:27.85 x 500
1y Target Est:37.77
Beta:-0.75
Next Earnings Date: 5-Nov-14NPSP Earnings announcement
Day's Range:27.41 - 28.89
52wk Range:21.60 - 39.68
Volume:1,713,520
Avg Vol (3m):2,044,770
Market Cap:2.95B
P/E (ttm):1,383.00
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NPSPDown 3.59%2.95B
ABTDown 1.89%62.54B
BIIBDown 5.42%72.99B

Key Statistics

Forward P/E (1 yr):24.05
P/S (ttm):15.77
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.02
Quarterly EPS Est (Sep-14) :0.01
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):12.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback